Supplementary Methods, Tables 1 - 2 from Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up

Autor:	Dirk Schadendorf, Philip Ströbel, Jürgen C. Becker, Martin Leverkus, Ivonne Kellner, Eckhardt Kämpgen, Rüdiger Hein, Axel Hauschild, Meinhard Schiller, Claudia Pföhler, Peter Mohr, Peter Helmbold, Jochen Utikal, Thomas Mentzel, Selma Ugurel
Rok vydání:	2023
Popis:	PDF file - 98K, Table 1. Toxicity of the intention to treat (ITT) population, classified and graded according to CTC 2.0 (http://ctep.cancer.gov/reporting/ctc.html). Data represent the worst CTC grade experienced by each patient. Table 2. Morphological and molecular tumor characteristics as analyzed in the per protocol (PP) population, for details see Patients and Methods. PDGFRB, platelet-derived growth factor receptor beta; EGFR, epidermal growth factor receptor; IR, insulin receptor; NA, not applicable.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2372158289b91f60602efa8bd4b9d0 https://doi.org/10.1158/1078-0432.22449429 Zobrazit plný text záznamu